Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cefradine
Viatris UK Healthcare Ltd
J01DB09
Cefradine
250mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010201; GTIN: 5016695291642
PATIENT INFORMATION LEAFLET CEFRADINE 250MG AND 500MG CAPSULES READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • IF YOU HAVE FURTHER QUESTIONS, PLEASE ASK YOUR DOCTOR OR YOUR PHARMACIST. • THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT TO OTHERS. IT MAY HARM THEM EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. • IF YOU GET ANY OF THE SIDE EFFECTS, TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. WHAT IS IN THIS LEAFLET 1. What Cefradine is and what it is used for 2. What you need to know before you take Cefradine 3. How to take Cefradine 4. Possible side effects 5. How to store Cefradine 6. Contents of the pack and other information WHAT CEFRADINE IS AND WHAT IT IS USED FOR Cefradine is an antibiotic and belongs to a family of medicines called cephalosporins. Cefradine capsules are used to treat a wide range of bacterial infections including: • tonsillitis • sinusitis • pharyngitis • laryngo-tracheo bronchitis • ear infections (otitis media) • chest infections (bronchitis or pneumonia) • skin infections • bladder, urethra (the tube which carries urine from the bladder) and kidney infections It is also used in the prevention of infections following surgical procedures associated with a high risk of infection. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CEFRADINE DO NOT TAKE CEFRADINE CAPSULES IF YOU: • are allergic to cefradine or any of the ingredients contained in this medicine; see section 6 Contents of the pack and other information. • are allergic to penicillin antibiotics • suffer with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking cefradine if: • you suffer from kidney problems, as you may require a lower dose than normal • you Les hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cefradine 250mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 250mg cefradine anhydrous For excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cefradine 250mg Capsules are used in the treatment of bacterial infections of the respiratory and urinary tracts and of the skin and soft tissues. These include the following: Upper respiratory tract infections - sinusitis, pharyngitis, tonsillitis, laryngo- tracheo bronchitis and otitis media. Lower respiratory tract infections - acute and chronic bronchitis, lobar and bronchopneumonia. Urinary tract infections - cystitis, urethritis and pyelonephritis. Skin and soft tissue infections - impetigo, abscess, cellulitis, furunculosis. Cefradine 250mg Capsules are also used in the prophylaxis of postoperative infections following surgical procedures associated with a high risk of infection and for patients with a reduced host resistance to bacterial infection. Cefradine should be administered immediately prior to surgery in order to ensure sufficient local tissue concentrations at the time that contamination is likely to occur. Treatment should be continued during the post operative period. Laboratory testing should be carried out to determine the causative agents and their sensitivity to cefradine. However, therapy may commence prior to receipt of the sensitivity test results. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults Respiratory tract infections and skin and soft tissue infections - the usual dose is 250mg or 500mg four times daily or 500mg or 1g twice daily depending on the severity and site of infection. Urinary tract infections - the usual dose is 500mg four times daily or 1g twice daily. This may need to be increased for severe or chronic infections. Prolonged intensive therapy is needed for complications such as prostatitis and epididymitis. Elderly As for adults. Patients with impaired renal or Les hele dokumentet